CA2701161C - Compositions lipidiques pour traiter des troubles gastro-intestinaux et favoriser les developpement et maturation intestinaux - Google Patents

Compositions lipidiques pour traiter des troubles gastro-intestinaux et favoriser les developpement et maturation intestinaux Download PDF

Info

Publication number
CA2701161C
CA2701161C CA2701161A CA2701161A CA2701161C CA 2701161 C CA2701161 C CA 2701161C CA 2701161 A CA2701161 A CA 2701161A CA 2701161 A CA2701161 A CA 2701161A CA 2701161 C CA2701161 C CA 2701161C
Authority
CA
Canada
Prior art keywords
fatty acids
use according
total
acid residues
total fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2701161A
Other languages
English (en)
Other versions
CA2701161A1 (fr
Inventor
Fabiana Bar Yosef
Gai Ben Dror
Tzafra Cohen
Yael Lifshitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzymotec Ltd
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40445529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2701161(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of CA2701161A1 publication Critical patent/CA2701161A1/fr
Application granted granted Critical
Publication of CA2701161C publication Critical patent/CA2701161C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/16—Fatty acid esters
    • A21D2/165—Triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention porte sur une utilisation d'une composition lipique pour la préparation d'une composition nutritionnelle, pharmaceutique ou nutraceutique ou un aliment fonctionnel, pour la prévention et le traitement de maladies et troubles gastro-intestinaux, et pour favoriser les développement, maturation, adaptation et différenciation intestinaux.
CA2701161A 2007-10-09 2008-10-02 Compositions lipidiques pour traiter des troubles gastro-intestinaux et favoriser les developpement et maturation intestinaux Expired - Fee Related CA2701161C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96066407P 2007-10-09 2007-10-09
US60/960,664 2007-10-09
PCT/IL2008/001311 WO2009047754A2 (fr) 2007-10-09 2008-10-02 Compositions lipidiques pour traiter des troubles gastro-intestinaux et favoriser les développement et maturation intestinaux

Publications (2)

Publication Number Publication Date
CA2701161A1 CA2701161A1 (fr) 2009-04-16
CA2701161C true CA2701161C (fr) 2014-01-14

Family

ID=40445529

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2701161A Expired - Fee Related CA2701161C (fr) 2007-10-09 2008-10-02 Compositions lipidiques pour traiter des troubles gastro-intestinaux et favoriser les developpement et maturation intestinaux

Country Status (12)

Country Link
US (3) US9107439B2 (fr)
EP (1) EP2207429B2 (fr)
KR (1) KR101354547B1 (fr)
CN (1) CN101896073B (fr)
AU (1) AU2008309140B9 (fr)
BR (1) BRPI0818079B8 (fr)
CA (1) CA2701161C (fr)
DK (1) DK2207429T4 (fr)
ES (1) ES2426591T5 (fr)
MX (1) MX2010003651A (fr)
RU (1) RU2469545C2 (fr)
WO (1) WO2009047754A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004820A (es) * 2007-11-01 2010-08-10 Enzymotec Ltd Mezcla lipidica para nutricion infantil.
US9491955B2 (en) 2008-08-25 2016-11-15 Brandeis University Balanced myristate- and laurate-containing edible oil
WO2011071367A1 (fr) * 2009-12-11 2011-06-16 N.V. Nutricia Effets d'empreinte métabolique de lipides structurés
NZ623342A (en) 2010-04-26 2014-12-24 Enzymotec Ltd Methods and lipid compositions for promoting development of gut flora
ES2674430T3 (es) * 2010-12-29 2018-06-29 Abbott Laboratories Producto nutricional para mejorar la tolerancia, digestión y absorción de nutrientes liposolubles en un lactante, niño pequeño o niño
AR092566A1 (es) * 2012-09-13 2015-04-22 Specialites Pet Food Composiciones grasas para mantener una palatabilidad de alimentos para animales domesticos en el tiempo
CN105072917B (zh) 2013-02-12 2019-05-03 荷兰洛德斯克罗科兰有限公司 脂肪组合物
JP6853665B2 (ja) * 2013-03-13 2021-03-31 プロラクタ バイオサイエンス，インコーポレイテッド 高脂質ヒト乳製品
EP2991508A1 (fr) * 2013-04-10 2016-03-09 Nestec S.A. Lait infantile à teneur faible en acides gras à chaîne moyenne et à teneur relativement élevée en acides gras insaturés, et son utilisation pour favoriser le bon établissement des fonctions cognitives chez les nourrissons
EP2986155A1 (fr) * 2013-04-10 2016-02-24 Nestec S.A. Lait infantile à faible teneur en acides gras à chaîne moyenne dans des proportions spécifiques et son utilisation pour favoriser et/ou assurer une croissance équilibrée chez les nourrissons
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
CN107529807A (zh) * 2015-05-04 2018-01-02 酶学技术有限公司 用于改善睡眠的脂质组合物
US20210392934A1 (en) * 2016-03-10 2021-12-23 Enzymotec Ltd. Lipid compositions and uses thereof
ES2930351T3 (es) 2016-04-15 2022-12-09 Evive Biotechnology Shanghai Ltd Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
CN107518382A (zh) * 2016-06-21 2017-12-29 丰益(上海)生物技术研发中心有限公司 一种提升肠道的中短链酸丰度的方法
EP3968787A1 (fr) 2019-05-15 2022-03-23 N.V. Nutricia Préparation pour nourrissons fermentée pour améliorer le développement intestinal
CN111011864A (zh) * 2019-12-27 2020-04-17 内蒙古蒙牛乳业（集团）股份有限公司 一种促进肠道健康的营养组分
WO2021164744A1 (fr) 2020-02-19 2021-08-26 Evive Biotechnology (Shanghai) Ltd Procédés de traitement d'une maladie du greffon contre l'hôte
AU2021253529A1 (en) 2020-04-09 2022-09-08 Société des Produits Nestlé S.A. Method for manufacturing sn-2 palmitic triacylglycerols
IL297288A (en) * 2020-04-27 2022-12-01 Nestle Sa A method for making products like milk
CN111700178A (zh) * 2020-06-16 2020-09-25 江南大学 一种罗非鱼油或其分提物的应用
CN115104651A (zh) * 2022-05-05 2022-09-27 上海交通大学 有效改善代谢的油脂组合物及其应用
CN116473132B (zh) * 2023-03-30 2024-02-13 江南大学 一种富含山柚油的组合物、制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2178752B (en) * 1985-07-12 1989-10-11 Unilever Plc Substitute milk fat
US4753963A (en) 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
WO1993021912A1 (fr) 1992-04-28 1993-11-11 Fresenius Ag Utilisation d'une emulsion contenant des acides gras omega-3 pour la fabrication d'un medicament administrable par voie parenterale, pour le traitement de maladies inflammatoires
EP0698078B1 (fr) * 1993-05-13 1997-08-20 Loders Croklaan B.V. Succedanes de matieres grasses de lait obtenus a partir de melanges interesterifies de triglycerides
HUP0300236A3 (en) 1997-02-21 2003-09-29 Univ Tennessee Res Corp Knoxvi Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation
PT893064E (pt) * 1997-07-22 2003-04-30 Nestle Sa Composicao lipidica para formulacao infantil e processo de preparacao
JP4175698B2 (ja) 1998-06-19 2008-11-05 サントリー株式会社 新規なトリグリセリド及びそれを含む組成物
EP1034704A1 (fr) † 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Composition nutritionnelle notamment pour la maturation gastro-intestinale spécifique dans des mammifères prématurés
EP1062873A1 (fr) * 1999-12-13 2000-12-27 N.V. Nutricia Aliment amélioré pour bébés, hydrolysat de protéines utilisables dans un tel aliment pour bébés, et procédé de préparation de cet hydrolysat
IL158555A0 (en) † 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
KR101368603B1 (ko) 2005-04-27 2014-02-27 엔지모테크 리미티드 모유 지방 대체물
EP1776877A1 (fr) 2005-10-21 2007-04-25 N.V. Nutricia Méthode de stimulation de la flore intestinale
WO2007058523A1 (fr) 2005-11-17 2007-05-24 N.V. Nutricia Composition comprenant de l'acide docosapentaenoique
WO2007088160A1 (fr) 2006-01-31 2007-08-09 Nestec S.A. Préparation nutritionnelle pour nourrissons présentant un poids faible à la naissance
EP2200443B2 (fr) 2007-09-17 2021-06-30 Cornell University Acides gras à chaîne ramifiée pour la prévention ou le traitement de troubles gastro-intestinaux
EP2143340A1 (fr) † 2008-07-07 2010-01-13 Nestec S.A. Composition nutritionnelle comprenant des acides aminés libres et des lipides structurés

Also Published As

Publication number Publication date
EP2207429A2 (fr) 2010-07-21
ES2426591T5 (es) 2017-08-16
US9107439B2 (en) 2015-08-18
US9561207B2 (en) 2017-02-07
CN101896073A (zh) 2010-11-24
MX2010003651A (es) 2010-07-05
EP2207429B1 (fr) 2013-06-05
KR20100106951A (ko) 2010-10-04
BRPI0818079A2 (pt) 2017-06-13
US20100273881A1 (en) 2010-10-28
KR101354547B1 (ko) 2014-01-22
DK2207429T4 (en) 2017-04-10
AU2008309140A1 (en) 2009-04-16
EP2207429B2 (fr) 2016-12-28
RU2010117211A (ru) 2011-11-20
WO2009047754A2 (fr) 2009-04-16
US8980949B2 (en) 2015-03-17
ES2426591T3 (es) 2013-10-24
DK2207429T3 (da) 2013-09-08
AU2008309140B9 (en) 2013-07-04
BRPI0818079B1 (pt) 2019-11-05
CA2701161A1 (fr) 2009-04-16
US20140187632A1 (en) 2014-07-03
BRPI0818079A8 (pt) 2017-10-03
WO2009047754A3 (fr) 2009-05-22
RU2469545C2 (ru) 2012-12-20
BRPI0818079B8 (pt) 2021-07-27
AU2008309140B2 (en) 2013-05-09
US20160030377A1 (en) 2016-02-04
CN101896073B (zh) 2013-11-20

Similar Documents

Publication Publication Date Title
US9561207B2 (en) Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
US8623825B2 (en) Edible fat composition for enhancing bone strength
JP2002138297A (ja) 油脂組成物
CN102791264B (zh) 用于预防或治疗糖尿病的油脂组合物
Höllwarth Short bowel syndrome: pathophysiological and clinical aspects
JP5739180B2 (ja) インスリン分泌促進用油脂組成物
JP2004075653A (ja) 体脂肪分解促進剤および飲食物
JP6422705B2 (ja) Ｇｉｐ上昇抑制剤
IL204926A (en) Lipid composition for the treatment of digestive disorders and to stimulate the development and maturation of the intestines
AU2017231043B2 (en) Lipid compositions and uses thereof
JPH10262607A (ja) 乳幼児用栄養組成物
TW202106336A (zh) 用於促進ｇｌｐ－１分泌之組成物
Yang et al. Early enteral fat supplementation improves protein absorption in premature infants with an enterostomy
JP2025081271A (ja) 慢性子宮内膜炎を治療するための組成物および方法
WO2024213708A1 (fr) Acide décanoïque et ses compositions destinés à être utilisés dans la prévention et/ou le traitement de troubles peroxysomiques
TW202042801A (zh) 用於促進酮體產生之組成物
HK1259452B (zh) 脂质组合物及其用途

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20211004